This is the best tl;dr I could make, original reduced by 57%. (I'm a bot)

The Civic party, one of Hong Kong's most prominent pro-democracy groups, has voted to disband because of a leadership vacuum, after its members were squeezed out of local councils and charged under Beijing's national security law.
Nicknamed "The barristers' party", it was founded in 2006 by professional elites - mostly from the legal sector - who wanted to promote democratisation and civil society in Hong Kong.
The party was among the last few opposition groups, as political dissent has been outlawed under 2020's national security law, and civil society in Hong Kong has been forced underground or driven into exile.
At its peak of popularity, the Civic party was the second-largest group in the opposition camp - pocketing six seats in Hong Kong's half-elected legislature in 2012.
By the end of 2021, the Civic party lost all five seats in Hong Kong's legislature and more than 30 spots in the democratically elected district councils, as authorities enforced Beijing's "Patriots only" doctrine for public offices.
The former founding member Albert Lai told Agence France-Presse the disbanding of the party "Can be deemed a symbol of the end of Hong Kong's nativistic democracy movement. But the failure does not mean the movement was meaningless."Many people were mobilised and much social capital was amassed during the process, which would be meaningful for the next chapter of Hong Kong.".

Summary Source FAQ Feedback Top keywords: party^#1 Hong^#2 Kong^#3 Civic^#4 pro-democracy^#5
Post found in /worldnews, /RedditSample, /TheColorIsBlue, /AutoNewspaper and /GUARDIANauto.
NOTICE: This thread is for discussing the submission topic. Please do not discuss the concept of the autotldr bot here.

Nir Barzilai is joining the show next week to do a deep dive on his work, biotechnology, and science. Looks like nothing is off the table, so we can have fun with where we go. This is for an ongoing series in biotechnology, longevity, and science. Please see below for a sampled list of other episodes.
Even if your question/comment doesn't get addressed, I will add it to a google doc for future guests to potentially answer instead.

Nir Barzilai

"Dr. Nir Barzilai is the director of the Institute for Aging Research at the Albert Einstein College of Medicine and the Director of the Paul F. Glenn Center for the Biology of Human Aging Research and of the National Institutes of Health’s (NIH) Nathan Shock Centers of Excellence in the Basic Biology of Aging. He is the Ingeborg and Ira Leon Rennert Chair of Aging Research, professor in the Departments of Medicine and Genetics, and member of the Diabetes Research Center and of the Divisions of Endocrinology & Diabetes and Geriatrics. Dr. Barzilai’s research interests are in the biology and genetics of aging. One focuses on the genetic of exceptional longevity, where we hypothesize and demonstrated that centenarians have protective genes, which allows the delay of aging or for the protection against age-related diseases. In a Program he is leading we take full advantage of phenotypes, DNA, and cells from the Ashkenazi Jewish families with exceptional longevity and the appropriate controls and his group have established at Einstein (over 2600 samples of which ~670 are centenarians) and discovered underling genomic differences associated with longevity. Longevity Genes Project (LGP) is a cross-sectional, on-going collection of blood and phenotype from families with centenarian proband. LonGenity is a longitudinal study of 1400 subjects, half offspring of parents with exceptional longevity, validating and following their aging in relationship to their genome. The second direction, for which Dr. Barzilai is holding an NIH Merit award that focuses on the metabolic decline of aging, and his team hypothesize that the brain leads this decline. His lab has identified several central pathways that specifically alter body fat distribution and insulin action and secretion by intraventricular or hypothalamic administration of several peptides that are modulated by aging including: Leptin, IGF-1, IGFBP3 and resveratrol. He has received numerous grants, among them ones from the National Institute on Aging (NIA), American Federation for Aging Research, the Ellison Medical Foundation and The Glenn Medical foundation. He has published over 280 peer-reviewed papers, reviews, and textbook chapters. He is an advisor to the NIH on several projects and serves on several editorial boards and is a reviewer for numerous other journals. Dr. Barzilai is in the Scientific Director and on the board of the American Federation for Aging Research, is its co-scientific director, and has served on several NIA study section. He is also a founder of CohBar Inc., a biotech that develops mitochondrial derived peptides as therapy for aging and its diseases and of Lifebioscince biotech. Dr. Barzilai has been the recipient of numerous prestigious awards, including the Beeson Fellow for Aging Research, the Ellison Medical Foundation Senior Scholar in Aging Award, the Paul F. Glenn Foundation Award, the NIA Nathan Shock Award, the 2010 Irving S. Wright Award of Distinction in Aging Research and the IPSEN Longevity Prize (2016). He is currently leading an international effort to approve drugs that can target aging. Targeting Aging with METformin (TAME) is a specific study designed to prove the concept that multi-morbidities of aging can be delayed by metformin, working with the FDA to approve this approach which will serve as a template for future efforts to delay aging and its diseases in humans. Born in Israel, Dr. Barzilai served as chief medic and physician in the Israel Defense Forces. He graduated from The Ruth and Bruce Rappaport Faculty of Medicine at the Technion-Israel Institute of Technology in Haifa and completed his residency in internal medicine at Hadassah Medical Center in Jerusalem. He served in a refugee camp during the war in Cambodia (1979-1980) and built a nutritional village in the homeland of the Zulu (1983 – Kwazulu). He has completed 2 fellowships at Yale (metabolism) and Corenell (Endocrinoology and molecular Medicine). He was an invited speaker to the 4th Israeli President Conference (2012) and a Vatican conference on efforts to enhance cures (2013, 2016). He has also taken part in Global initiatives and spoke at The Milken Global Institute, Asian Megatrends and is an advisor for the Prime Minister of Singapore on Aging. Dr. Barzilai has been on the ‘Forward 50, top 50 influence Jews in the US (2011). His work has been profiled by major outlets, including the New York Times, the BBC and PBS' NOVA science now, TEDMED and several TEDx talk is the leading feature on the Ron Howard/Jonathan Silberberg/National Geographic film about the Age of Aging. He authored Age Later (2019)"

Finally, Please check out the other episodes in the series thus far:

​

1. Aubrey De Grey - LEV
2. Varun Dwaraka - Bio aging clocks
3. Mark Hamalainen - longevity biotech fellowship
4. Oki O'Connor - Cyclodextrin and Cyclodextrin
5. Kevin Perrott - OpenCures
6. Christin Glorioso - Brain Longevity & Metformin issues
7. Jay Sarkar - Turn Biotechnologies and innovation
8. Robin Mansukhani - Immune Senolytic Drugs
9. George Church - Synthetic biology
10. Lisa Fabiny-Kiser - SENS
11. Jennifer Garrison - Reproductive longevity
12. Stephanie Dainow- Lifespan.io
13. Sebastian Brunemeier - Immune System Rejuvenation
14. Michael Forrest - Metabolism & Longevity
15. Bjorn Schumacher - DNA repair mechanisms
16. Nikolina Lauc - Glycome and aging
17. Eric Leire - Gene therapy and aging
18. Collin Ewald - Extracellular Matrix
19. Matt Kaeberlein- Rapamycin & Longevity

Also, consider subscribing we have some interesting things planned for when the youtube channel gets to its first 1,000 subscribers. Livestreams, twitter spaces, clubhouse, etc.

Nir Barzilai is joining the show next week to do a deep dive on his work and the longevity space. Looks like nothing is off the table, so we can have fun with where we go. This is for an ongoing series in biotechnology, longevity, and science. Please see below for a sampled list of other episodes.
Even if your question/comment doesn't get addressed, I will add it to a google doc for future guests to potentially answer instead.

Nir Barzilai

"Dr. Nir Barzilai is the director of the Institute for Aging Research at the Albert Einstein College of Medicine and the Director of the Paul F. Glenn Center for the Biology of Human Aging Research and of the National Institutes of Health’s (NIH) Nathan Shock Centers of Excellence in the Basic Biology of Aging. He is the Ingeborg and Ira Leon Rennert Chair of Aging Research, professor in the Departments of Medicine and Genetics, and member of the Diabetes Research Center and of the Divisions of Endocrinology & Diabetes and Geriatrics. Dr. Barzilai’s research interests are in the biology and genetics of aging. One focuses on the genetic of exceptional longevity, where we hypothesize and demonstrated that centenarians have protective genes, which allows the delay of aging or for the protection against age-related diseases. In a Program he is leading we take full advantage of phenotypes, DNA, and cells from the Ashkenazi Jewish families with exceptional longevity and the appropriate controls and his group have established at Einstein (over 2600 samples of which ~670 are centenarians) and discovered underling genomic differences associated with longevity. Longevity Genes Project (LGP) is a cross-sectional, on-going collection of blood and phenotype from families with centenarian proband. LonGenity is a longitudinal study of 1400 subjects, half offspring of parents with exceptional longevity, validating and following their aging in relationship to their genome. The second direction, for which Dr. Barzilai is holding an NIH Merit award that focuses on the metabolic decline of aging, and his team hypothesize that the brain leads this decline. His lab has identified several central pathways that specifically alter body fat distribution and insulin action and secretion by intraventricular or hypothalamic administration of several peptides that are modulated by aging including: Leptin, IGF-1, IGFBP3 and resveratrol. He has received numerous grants, among them ones from the National Institute on Aging (NIA), American Federation for Aging Research, the Ellison Medical Foundation and The Glenn Medical foundation. He has published over 280 peer-reviewed papers, reviews, and textbook chapters. He is an advisor to the NIH on several projects and serves on several editorial boards and is a reviewer for numerous other journals. Dr. Barzilai is in the Scientific Director and on the board of the American Federation for Aging Research, is its co-scientific director, and has served on several NIA study section. He is also a founder of CohBar Inc., a biotech that develops mitochondrial derived peptides as therapy for aging and its diseases and of Lifebioscince biotech. Dr. Barzilai has been the recipient of numerous prestigious awards, including the Beeson Fellow for Aging Research, the Ellison Medical Foundation Senior Scholar in Aging Award, the Paul F. Glenn Foundation Award, the NIA Nathan Shock Award, the 2010 Irving S. Wright Award of Distinction in Aging Research and the IPSEN Longevity Prize (2016). He is currently leading an international effort to approve drugs that can target aging. Targeting Aging with METformin (TAME) is a specific study designed to prove the concept that multi-morbidities of aging can be delayed by metformin, working with the FDA to approve this approach which will serve as a template for future efforts to delay aging and its diseases in humans. Born in Israel, Dr. Barzilai served as chief medic and physician in the Israel Defense Forces. He graduated from The Ruth and Bruce Rappaport Faculty of Medicine at the Technion-Israel Institute of Technology in Haifa and completed his residency in internal medicine at Hadassah Medical Center in Jerusalem. He served in a refugee camp during the war in Cambodia (1979-1980) and built a nutritional village in the homeland of the Zulu (1983 – Kwazulu). He has completed 2 fellowships at Yale (metabolism) and Corenell (Endocrinoology and molecular Medicine). He was an invited speaker to the 4th Israeli President Conference (2012) and a Vatican conference on efforts to enhance cures (2013, 2016). He has also taken part in Global initiatives and spoke at The Milken Global Institute, Asian Megatrends and is an advisor for the Prime Minister of Singapore on Aging. Dr. Barzilai has been on the ‘Forward 50, top 50 influence Jews in the US (2011). His work has been profiled by major outlets, including the New York Times, the BBC and PBS' NOVA science now, TEDMED and several TEDx talk is the leading feature on the Ron Howard/Jonathan Silberberg/National Geographic film about the Age of Aging. He authored Age Later (2019)"

Finally, Please check out the other episodes in the series thus far:

​

1. Aubrey De Grey - LEV
2. Varun Dwaraka - Bio aging clocks
3. Mark Hamalainen - longevity biotech fellowship
4. Oki O'Connor - Cyclodextrin and Cyclodextrin
5. Kevin Perrott - OpenCures
6. Christin Glorioso - Brain Longevity & Metformin issues
7. Jay Sarkar - Turn Biotechnologies and innovation
8. Robin Mansukhani - Immune Senolytic Drugs
9. George Church - Synthetic biology
10. Lisa Fabiny-Kiser - SENS
11. Jennifer Garrison - Reproductive longevity
12. Stephanie Dainow- Lifespan.io
13. Sebastian Brunemeier - Immune System Rejuvenation
14. Michael Forrest - Metabolism & Longevity
15. Bjorn Schumacher - DNA repair mechanisms
16. Nikolina Lauc - Glycome and aging
17. Eric Leire - Gene therapy and aging
18. Collin Ewald - Extracellular Matrix
19. Matt Kaeberlein- Rapamycin & Longevity

Also, consider subscribing we have some interesting things planned for when the youtube channel gets to its first 1,000 subscribers. Livestreams, twitter spaces, clubhouse, etc.

Job Title	Company	Location	Country	Skills
Senior Data Engineer (m/f/d)	AllCloud	Germany	Germany	SQL, AWS
Data Analyst/Developer	Actalent	Durham	Remote	Tableau, Data Visualization, Scala
Data Engineer	Veritas Technologies LLC	Bengaluru	India	SQL
Affirmative Action / EEO Data Analyst – Remote	Ogletree Deakins	Chicago	Remote	AWS
Operations data analyst	Europ Assistance	L’île-Saint-Denis	France	Python
Senior Data Engineer	Skillable	Raleigh	Remote	SQL
Senior Machine Learning Engineer	Albert Heijn	Zaandam	Netherlands	Machine Learning, Scala
Associate Data Analyst	Skillable	Raleigh	United States	Power BI
Data Engineer	BillEase	Hong Kong SAR	Hong Kong	Spark, Hadoop, Scala
Data Analyst	BillEase	Andorra	Spain	Python, SQL, Data Mining
AWS Data Engineer	NTT DATA Italia	Cosenza	Italy	AWS, Scala
Digital Marketing Data Analyst - Remote	Talentify.io	United States	Remote	Data Visualization, Tableau, Looker
Online Data Analyst	TELUS International	County Westmeath	Ireland	Machine Learning
Data Analyst Intermediate	LOG.IT srl	Rome	Italy	Business Intelligence
Data Engineer	Veritas Technologies LLC	Pune	India	SQL
Data Scientist	Escalent	Greater Kolkata Area	India	SQL, Data Visualization, Power BI
Audit Data Analyst	Marathon Petroleum Corporation	Denver	United States	ETL
DATA ANALYST (M/F)	MC	Porto	Portugal	Business Intelligence, Machine Learning, Data Mining
Data Analyst	Dice	Ridgefield	United States	Java, Python, Data Visualization
Senior Data Scientist (d/m/w) Industrial Processes	thyssenkrupp	Bavaria	Germany	SQL
Data Engineer (Remoto)	GeekHunter Brasil	São Paulo	Brazil	AWS
Machine Learning Data Engineer	Pattern®	Pune	India	Machine Learning
Infrastructure Data Analyst - Remote - US ($78200....	Talentify.io	United States	Remote	Power BI, Modeling, Business Intelligence

Hi, here are 23 New Data Science, Data Engineering and Machine Learning jobs.
For more, check our Google sheet with more opportunities in Data Science and Machine Learning (updated each week) here
If you want to take some Data and ML courses, click here
Let me know if you have any questions. Cheers!

Random encounter, although they’ve heard about each other in passing. In character. Standard equipment. Fight takes place in the Bronx.
Albert Respect Thread
Goblin Respect Thread

Hiperoff adalah hasil kompleks melawan hipertensi yang disajikan dalam bentuk kapsul. Mereka mengompol mengurangi tekanan darah tinggi serta semua gejala yang berhubungan dengan kondisi ini. Hiperoff asli memberikan perawatan berkualitas tinggi untuk kesehatan dan fungsi normal sistem kardiovaskular.
Selain itu, tidak memicu kontraindikasi karena kandungannya berasal dari herbal. Ini telah berhasil lulus semua tes yang dibutuhkan. Dalam lingkungan ini, kita perlu menyebutkan bahwa produk Hiperoff adalah suplemen makanan, bukan obat.
>>> KLIK DI SINI UNTUK MEMBELI – SITUS RESMI – DISKON 50% TERSEDIA <<<
Sampai sekarang, eksplorasi utama kami menunjukkan bahwa kapsul untuk hipertensi sebelumnya sebagian besar populer di daratan yang berbeda. Tamu yang puas dari Indonesia setiap hari positif pasca ulasan dan saksi Hiperoff pada tahun 2022. Mereka mengklaim bahwa produk tersebut tidak hanya menormalkan tekanan darah tetapi juga menghilangkan trombosis vena dan aritmia.
Ini juga telah didirikan oleh laboratorium terkenal untuk kondisi kardiovaskular. Juga, harga bio-solusi untuk tekanan darah tinggi relatif menggoda saat ini.
Kapsul Hiperoff tersedia di banyak negara. Hiperoff dapat dipesan di Malaysia, Kenya, Nigeria, India, Afrika Selatan, Peru, Singapura, Filipina, Maroko, Irak, dan lain-lain. Kapsul mungkin dengan paket yang berbeda di berbagai negara. Ini bukan alasan untuk khawatir - konstituennya sama dan barang-barang operasinya juga. Orang-orang di Kenya, Nigeria, India, Afrika Selatan, Peru, Singapura, Filipina, dan Irak hanya berbagi pendapat dan komentar positif tentang kapsul Hiperoff.

Bioflavonoid – Pentingnya Kesehatan & Manfaat

Bioflavonoid adalah istilah umum yang digunakan untuk berhubungan dengan komposit polifenol pabrik yang aktif secara biologis yang dikenal sebagai flavonoid. Mereka pertama kali ditemukan pada tahun 1936 oleh pemenang Nobel Albert. George, yang pertama kali menganggap mereka sebagai "vitamin P". Sejak itu juga, ribuan bioflavonoid telah dihubungkan dan diklasifikasikan menurut struktur kimianya yang berbeda.
Beberapa dari mereka, yang telah mengucapkan paket yang bermanfaat, digunakan dalam obat-obatan dan dapat ditanam dalam bentuk suplemen makanan – sendiri atau dalam formula gabungan. Spesialis medis mengambil bagian dalam pendapat bahwa unsur-unsur mikro ini adalah bagian penting dari nutrisi yang tepat karena mereka memiliki efek antioksidan yang kuat. Bioflavonoid ditanam secara substansial dalam buah-buahan dan sayuran, serta dalam makanan yang mirip dengan cokelat hitam dan anggur.
Manfaat kesehatan yang paling penting dari bioflavonoid adalah

• Memperbaiki aliran darah dan memperbaiki fungsi jantung;
• Kontrol tekanan darah;
• Menghambat enzim yang menghasilkan revolusioner bebas dalam tubuh;
• Kecualikan revolusioner bebas sebelum mereka dapat merusak sel;
• Meningkatkan pertahanan antioksidan dalam tubuh;
• Memperbaiki keseimbangan zat dalam tubuh.

Apa Itu Hiperoff – Kapsul untuk Kontrol Tekanan Darah

Hiperoff adalah obat organik yang bekerja untuk hipertensi dalam bentuk kapsul herbal. Secara alami menyeimbangkan kembali tekanan darah dalam waktu 6 jam karena bioflavonoid yang dikandungnya. Selain itu, jika Anda mengajukan pertanyaan yang mirip dengan "Hiperoff untuk apa?" kami harus memberi tahu Anda bahwa suplemen juga mengembalikan nada dan kejelasan pembuluh dalam satu kali perawatan. Ini aman untuk segala usia dan tidak menyebabkan barang sampingan yang tidak diinginkan atau kontraindikasi berbahaya lainnya. Produk Hiperoff memiliki satu poin utama – isinya mencakup komponen yang disimpulkan dari saus dan toko yang fantastis dan langka.
>>> KLIK DI SINI UNTUK MEMBELI – SITUS RESMI – DISKON 50% TERSEDIA <<<

Manfaat dan Keuntungan Suplemen

Selain semua yang dikatakan, kami ingin mengambil bagian bersama Anda daftar pendek yang menjelaskan beberapa paket kesehatan terpenting dari produk Hiperoff.

• Mempertahankan posisi normal tekanan darah sepanjang waktu;
• Mencegah tombak drastis atau penurunan tekanan;
• Mengatur fungsi halus jantung;
• Mempromosikan peningkatan kesehatan secara keseluruhan;
• Hasil yang efektif tanpa barang sampingan.

Hiperoff – Ulasan Tamu

Menariknya, kapsul organik untuk hipertensi mencetak hasil yang tak terbayangkan di daratan yang berbeda saat tamu dari Indonesia menulis ulasan dan saksi Hiperoff positif pada tahun 2022. Sebagian besar tamu cenderung menulis cerita tertentu yang menggambarkan barang-barang bermanfaat dari suplemen untuk tekanan darah tinggi.
Ini membuktikan bahwa produk Hiperoff menikmati ulasan pujian yang dibenarkan di forum Internet dan pintu web diskusi saat ini. Beberapa tamu juga mengambil bagian bahwa harga kapsul herbal sangat terjangkau. Selain itu, secara cepat mengurangi tanda-tanda hipertensi – tekanan darah tinggi, sakit kepala, pusing, dan aritmia. Akibatnya, semakin banyak ulasan Hiperoff positif muncul hari demi hari. Anda dapat menemukan dan membacanya terutama di setiap tempat.
Cara Makan Hiperoff Original – Petunjuk Penggunaan
Untuk mencapai efektivitas optimal dari kursus perawatan, Anda perlu membaca dan mengikuti petunjuk penggunaan Hiperoff. Pikirkan tablet hisap diurnal dan detail lain yang terkait dengan input kapsul.
Petunjuk penggunaan Hiperoff original adalah

• Minum 1 kapsul 2-3 kali sehari 30 binar setelah berantakan;
• Untuk hasil yang maksimal, dianjurkan untuk mengambil produk dalam waktu 3 bulan;
• Cari instruksi terperinci di dalam paket.
• Kontraindikasi & Side Goods

Hiperoff biasanya tidak terkait dengan barang sampingan dan kontradiksi yang mungkin karena kandungannya adalah sumber herbal. Ini berarti bahwa Anda dapat melakukan perawatan penuh dengan kapsul tanpa melewati tanggapan yang tidak diinginkan.

Konten dan Konstituen Penting

Kandungan Hiperoff adalah 100 organik dan telah teruji klinis dan dinilai efektif. Ini adalah hasil dari kombinasi konstituen herbal dengan manfaat kesehatan yang penting. Kapsul menggunakan barang-barang positif dari kutipan warna-warni, yang membantu menyeragamkan tekanan darah dan mempertahankan fungsi normal jantung. Jika Anda ingin tahu lebih jauh tentang faktor-faktor spesifik yang termasuk dalam konten asli produk Hiperoff, Anda dapat menemukan detailnya di pamflet yang disertakan dalam paket.

Hiperoff – Harga di Indonesia – Tempat Membeli

Jika Anda bertanya-tanya seberapa penting Hiperoff dan di mana membelinya – kami akan membantu Anda dalam hal ini. Anda dapat membeli produk Hiperoff asli dengan harga yang luar biasa dengan memesannya secara online. Satu-satunya tempat yang memungkinkan ini adalah situs web khusus kapsul herbal untuk hipertensi. Ini adalah bagaimana Anda bisa membeli Hiperoff dengan harga terjangkau di Indonesia.
Namun, Anda mungkin cocok untuk mendapatkan keuntungan dari beberapa juggernauts pengurangan segar dan penawaran promo, jika Anda memeriksa pelari web suplemen terhadap hipertensi secara teratur. Ini secara teratur digerakkan oleh distributor merek.
>>> KLIK DI SINI UNTUK MEMBELI – SITUS RESMI – DISKON 50% TERSEDIA <<<

Apakah itu dijual di Farmasi dan Watson?

Anda tidak akan menemukan produk Hiperoff di apoteker, Watson, atau Amazon. Anda hanya dapat menemukan dan membeli suplemen otentik dari pelari web khusus. Dalam lingkungan ini, merek apa pun yang dianalogikan dengan Hiperoff dan Anda melihatnya di toko obat, Watson, dll. adalah biola dan reproduksi palsu. Ini berarti Anda harus menghindari produk ini karena mereka menyembunyikan beberapa jebakan tersembunyi untuk kesehatan Anda. Jadi, ikuti saran kami dan jangan mencari Hiperoff di apotek.
https://www.mycast.io/stories/hiperoff-ulasan-2022-apakah-baik-untuk-hati-anda?added=true

1) In response to Mercédès’ gratitude to the count for securing Albert’s safety, the count remarks that saving a man, sparing his father from torment, and calming the sensitive nature of a woman are components not of a good deed but of a humane act. Do you think Fernand recognizes the bitter irony of the count’s words? And has the count effectively abandoned his humanity and essentially become a vampire, able to be satisfied only by the destruction of others?
2) The narrator identifies Mercédès—but not Fernand—by name; why the differing treatment?
3) Do you think Mercédès already knows who the count is? And do you think she would give up her life to be reunited with Dantès?
Final sentence of chapter:
“‘Most decidedly,’ said he, ‘men are not equal, and I must beg my father to develop this theorem in the Chamber of Peers.”
previous chapter discussion

For all of my AP exams, I received Form O (the standard form). But for AP Calculus BC, I received Form E (the experimental form). The exam I felt was more difficult than practice I've done; I ran out of time for multiple choice (I had to just put C for several problems on the no-calculator multiple choice) and I ran out of time to finish FRQ 6 because of some challenging problems.
Despite this, I think I got a 5 putting in what I think I scored on the albert.io and other score calculators. Several of my classmates got different versions of the exam than me (I know this from post-exam discussions I've had with them regarding some FRQs).
Now, with my horrible exam experience, does form E (the experimental form) require fewer points to earn a 5 than form O?

For me, the MCQ had like 10 tricky questions, but I definitely choked the FRQs, so MCQ better carry. Praying for a 5, happy with a 4. What do you guys think will be the cutoff for a 5 this year? I'm questioning the accuracy of the Albert IO score calculators because students from past years say that they know they got a 3 or 4 on Phys 2 based on the score calculator, but they actually got a 5.

hi so i just took ap world today and i don't think i did well. that being said the two score calculators i use have drastically different predictions:
albert io says literally 46 mcq 222 saq 5 dbq 4 leq is a 4
while my teacher's calculator for the 2020 mock exam provided by collegeboard says literally change the mcq to 40 and its still a 5
what i find really weird about the albert io calculator is the fact that the score they give you for mcq is lower than the number of questions you get right. so i'd like to know, which scoring system is more accurate?

This is the best tl;dr I could make, original reduced by 67%. (I'm a bot)

Adhara Pérez Sánchez, an 11-year-old girl from Mexico City, is set to achieve a remarkable feat by obtaining her Master's degree at a very young age.
Adhara, who has been tested to have a higher IQ than two of the greatest physicists, Albert Einstein and Stephen Hawking, scored an impressive 162 on her IQ test.
"She was very depressed, people did not have empathy, they made fun of her," Adhara's mother, Nayeli Sánchez, was quoted as saying by the magazine.
To help her daughter cope with the bullying, Adhara's mother enrolled her in therapy and then to the Center for Attention to Talent, a school for gifted children.
Her incredible IQ was confirmed at the school, and she finished elementary school at the age of five, followed by middle and high school in just one year.
Despite the challenges, Adhara remained determined and continues to inspire people worldwide.

Summary Source FAQ Feedback Top keywords: Adhara^#1 school^#2 mother^#3 Sánchez^#4 University^#5
Post found in /worldnews.
NOTICE: This thread is for discussing the submission topic. Please do not discuss the concept of the autotldr bot here.

i'm trying to use the albert.io score calculator for calc bc but I have no idea what Section II: Free Response - Question 5 (AB Part) even means. do you guys know what question that is?

I took 3 APs this year which were AP Calc BC, AP Comparative government and AP CSP. I have no idea what I did in AP Calc, i think like a 3? 4? but definitely not 5. I think I did really well in AP Comp and AP CSP but I am scared that I might not get 5s but instead 4.
I’m a senior and a university asked me to get one singular score of 5 on an ap test this year to accept me and I’m so scared that I’m not going to get it. I think I genuinely did well and all but I’m just soooo scared that I might end up being wrong when scores come out in July. I did the Albert.io score calculator for Comp Gov and with 40/55 in mcqs and 5 points off in the frq I was still firmly in the 5 category but I’m still so scared that I’m not going to get a 5.
For APCSP, I really have no way to know how much I will get in the create task since my teacher didn’t grade it or even look at it. I worked really hard on the app and I studied for the mcq test and I think I did every question in the test correctly except 2 or 3 questions but the Albert.io calculator shows that the curving is really really really harsh so I am just sooooo scared. What do you guys think? Am I doomed?

Scrambly is a website that you can do offers & play games in order to redeem money to PayPal. If you need more proof that it really pays out, go to my profile and look at the comments on my Scrambly posts :)
Use my link to sign up: https://scrambly.io/?code=D4J2LR_EeK9O&type=aff
Do offers such as, Sirius, Spruce, iHeart Radio, Albert, Financial Aid Authority, Haus Survey Panel, crypto (dot com) — etc. (Look for offers that say FAST AND MEDIUM)
Do games such as, Scramble, Crossword, Yahtzee.
It’ll ask for your ID during your first CASHOUT just to verify you’re you.
Dm for information. Link is above.

By higher I mean you will need to get a higher score to get a 5 compared to last year. Last year you needed a 62/108 for a 5 (according to Albert io). I’m p sure I got between a 67-72 on this, and I’m lwk stressing that they’ll increase the curve to be like 70 and I’ll be literally cut off by 3 points.

Albert.io, etc. How accurate are they to what the actual cutoffs are? I know they’re based on previous years, so do the cutoffs change for year to year?

Hey everyone,
I'm a fairly beginner Excel user working with a mess of data, trying to organize a set that is structured like the example image linked here.
I'm trying to recall all the user names/emails of individuals tied to specific products spread across several product name columns in different orders.
You can see these products were registered to users in different orders, so product A can live in Product 1 for Joe Smith, or Product 2 and Product 3 for Albert Nameson and Jenny Smith respectively.
My goal: create a formula or table that outputs multiple users based on the product name I select.
For example, I want to show all the users with ties to product A, regardless of what order A appears in their row. So if I selected product A as the input, my output would be Joe Smith, Jane Doe, Albert Nameson, Jenny Smith, Tom Wilson, and Henry Kissinger.
Essentially just pivoting onto a product by product basis to list out all the users attached to them across the product columns.
Does that make sense? I feel like this is something extremely simple but can't be satisfied by xlookup or filter. Any suggestions would be greatly appreciated.

Just took the APCSP exam and do any of you know how the APCSP exam is graded? My teacher is saying that you need a combined 70 points out of the 100 possible points (Creative Performance Task + Multiple Choice) for a 5, the Princeton Review Textbook says you need a combined 105/150 points for a 5, and some other sources like albert.io say you need 90% total out of both the Creative Performance Task and Multiple Choice for a 5. So do any of you guys know which one is correct if any are correct and what is the correct estimate.

was the albert io calculator for apcsp accurate for 2022?? it seemed so wack tbh
if it is…💀💀 hoping the curve is better this year

Hello! Would be grateful if anyone could tell me the usual cutoff for a 5 in Calc BC. People say albert.io is not reliable - any help will be appreciated. I just hope the curve isn't too harsh because I messed up the FRQs